Acquired hemophilia A
ORPHA:599480DiseaseNot applicableAdolescent, Adult, Childhood, Elderly
Эпидемиология14
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | Unknown | — | Europe | Class only |
| Annual incidence | 1-9 / 1 000 000 | 0.1505 | Europe | Value and class |
| Point prevalence | Unknown | — | United Kingdom | Class only |
| Annual incidence | 1-9 / 100 000 | 0.141 | United Kingdom | Value and class |
| Point prevalence | 1-9 / 1 000 000 | 0.3063 | Spain | Value and class |
| Annual incidence | <1 / 1 000 000 | 0.0829 | Spain | Value and class |
| Point prevalence | Unknown | — | Germany | Class only |
| Annual incidence | 1-9 / 1 000 000 | 0.6 | Germany | Value and class |
| Point prevalence | Unknown | — | Australia | Class only |
| Annual incidence | 1-9 / 1 000 000 | 0.12 | Australia | Value and class |
| Point prevalence | Unknown | — | Japan | Class only |
| Annual incidence | <1 / 1 000 000 | 0.097 | Japan | Value and class |
| Point prevalence | Unknown | — | Switzerland | Class only |
| Annual incidence | 1-9 / 1 000 000 | 0.45 | Switzerland | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)